Authors:
Cemazar, M
Miklavcic, D
Mir, LM
Belchradek, J
Bonnay, M
Fourcault, D
Sersa, G
Citation: M. Cemazar et al., Electrochemotherapy of tumours resistant to cisplatin: a study in a murinetumour model, EUR J CANC, 37(9), 2001, pp. 1166-1172
Authors:
Baudin, E
Pellegriti, G
Bonnay, M
Penfornis, A
Laplanche, A
Vassal, G
Schlumberger, M
Citation: E. Baudin et al., Impact of monitoring plasma 1,1-dichlorodiphenildichloroethane (o,p ' DDD)levels on the treatment of patients with adrenocortical carcinoma, CANCER, 92(6), 2001, pp. 1385-1392
Authors:
Fizazi, K
Ducreux, M
Ruffie, P
Bonnay, M
Daniel, C
Soria, JC
Hill, C
Fandi, A
Poterre, M
Smith, M
Armand, JP
Citation: K. Fizazi et al., Phase I, dose-finding, and pharmacokinetic study of raltitrexed combined with oxaliplatin in patients with advanced cancer, J CL ONCOL, 18(11), 2000, pp. 2293-2300
Authors:
Ducreux, M
Ychou, M
Seitz, JF
Bonnay, M
Bexon, A
Armand, JP
Mahjoubi, M
Mery-Mignard, D
Rougier, P
Citation: M. Ducreux et al., Irinotecan combined with bolus fluorouracil, continuous infusion fluorouracil, and high-dose leucovorin every two weeks (LV5FU2 regimen): A clinical dose-finding and pharmacokinetic study in patients with pretreated metastatic colorectal cancer, J CL ONCOL, 17(9), 1999, pp. 2901-2908
Authors:
Lindemans, J
Hoefkens, P
van Kessel, AL
Bonnay, M
Kulpmann, WR
van Suijlen, JDE
Citation: J. Lindemans et al., Portable blood gas and electrolyte analyzer evaluated in a multiinstitutional study, CLIN CHEM, 45(1), 1999, pp. 111-117